Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

AI company launches data project to predict spread of viruses

Jvion, an AI-enabled prescriptive analytics company, has launched a data analysis project that aims to find patterns in the spread of viruses that cause acute respiratory illness like the new coronavirus, dubbed COVID-19.

Thumbnail

Judge recommends revoking license of UCLA cardiologist accused of sexual assault

A California judge is recommending that a University of California, Los Angeles cardiologist accused of sexually assaulting three women have his medical license revoked.

Thumbnail

Teleradiology firm launches ‘first of its kind’ coronavirus screening program

USARad said it’s mobilizing a network of chest CT-trained rads to diagnose and consult patients with COVID-19. 

Thumbnail

Imaging specialists raise $11M for AI-powered lung disease detection

VIDA Diagnostics, a Coralville, Iowa-based imaging technology company, has announced the completion of a Series C financing round worth $11 million.

Thumbnail

Microsoft signs deal to sell AI-powered blood tests for CVD

Microsoft has signed a new deal with Prevencio, a cardiovascular health company based in Kirkland, Washington, to market and sell AI-powered cardiac blood tests to the public.

Thumbnail

Non-US citizens less likely to receive treatment for CV ills

U.S.-born and -naturalized citizens are far more likely than noncitizens to receive treatment for CVD risk factors, researchers reported in Circulation this month.

Thumbnail

EHRA 2020 in Vienna canceled over coronavirus concerns

The event was scheduled to occur March 29-31 in Vienna.

AHA criticized for faulty marketing partnership with Bayer

The American Heart Association is facing criticism after partnering with Bayer to promote the company’s low-dose aspirin in Walmart pharmacies across the U.S., STAT reported March 9.